Researchers have discovered sequence-specific interactions between hepatitis B proteins and pre-genome RNA that may play a crucial role in nucleocapsid assembly. This could be targeted in future drug development.
Author, Khaled Barakat, argues that computational modeling has a great potential in directing hepatitis research, to understand the liver and to discover better and more effective treatments.
Reporting from ECCMID17, we spoke to William Irving about his current work on hepatitis C and his thoughts on the future of this field.
Viral hepatitis is a leading cause of mortality and morbidity worldwide, take a look at our infographic to uncover more about this disease, its burden and the current treatment options.
In this clinical trial focus, the authors discuss difficult-to-treat patients with autoimmune hepatitis, and the potential of additional treatment option JKB-122.
Genotyping hepatitis C patients with advanced cirrhosis could help predict improvement after treatment, according to research presented at Digestive Disease Week®.
In this interview, Joop Arends discusses his thoughts on the future of diagnosis and management of hepatitis C, and also gives us his highlights from ECCMID.
In line with Hepatitis Awareness Month, we spoke to Marcus Dorner about his current research into the host–virus interactions in hepatitis B and C infection, their implications for vaccine development and more.
Immunization is reported to be one of the most successful and cost-effective health interventions in human history – find out more in our exclusive infographic exploring the key facts.
Researchers have demonstrated that both hepatitis B and hepatitis C infection are associated with an increased risk of Parkinson’s disease.
